The need for continued education is critical in these uncertain times. Therefore, the co-directors of the Fall Clinical Dermatology Conference are excited to announce our new program: the Fall Clinical Virtual Grand Rounds (FCVGR). This new online series is designed to help maintain the educational opportunities one would have if they were able to attend grand rounds in person.
FCVGR will consist of eight weekly CME sessions on a variety of dermatological diseases and tools.
The Wednesday May 20, 2020 session is now available on demand. EVOLVING CONCEPTS IN DERMATOLOGY PART III Lawrence Eichenfield, MD: What's New in Peds Derm and Atopic Dermatitis Theodore Rosen, MD: STDs in the Era of Social Distancing
Professor of Dermatology and Pediatrics
University of California
San Diego, CA
Theodore Rosen, MD
Faculty
Professor of Dermatology
Baylor College of Medicine
Chief of the VA Dermatology Service
VA Medical Center
Houston, TX
Upon completion of this activity, the participant should be better able to:
Recognize the disease impact of moderate to severe atopic dermatitis and be aware of evolving therapeutic agents
Recognize the factors favoring both increase and decrease in sexually transmitted disease related to the current COVID-19 pandemic
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and the Foundation for Research and Education in Dermatology. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by educational grants from Almirall, Bristol-Myers Squibb, and Mayne Pharma.
CONFLICTS OF INTEREST/DISCLOSURES
Lawrence Einchfield, MD
Consultant: Anacor/Pfizer, Dermavant, Dermira, DS Biopharma, Forte, Galderma, Glenmark/Ichnos, Incyte, Leo Pharma, Lilly, Matrisys, Novartis, Sanofi/Regeneron, TopMD, and Ortho Dermatologics.
Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.